Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas

NCT00033280 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

NETWORK

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: temozolomide
PROCEDURE: neoadjuvant therapy
RADIATION: radiation therapy

Sponsor

Radiation Therapy Oncology Group

Collaborators

[object Object]
[object Object]